*Bactericidal and Bacteriostatic Antibiotics DOI: http://dx.doi.org/10.5772/intechopen.99546*


## **Table 12.**

*<sup>3</sup>A V quinolones.*



#### **Table 13.**

*3A VI penicillin (beta-lactams).*


*Bactericidal and Bacteriostatic Antibiotics DOI: http://dx.doi.org/10.5772/intechopen.99546*


#### **Table 14.**

*3A VII cephalosporins.*



#### **Table 15.**

*3A VIII beta-lactamase inhibitors and beta-lactam combinations.*


#### **Table 16.**

*3A IX monobactams.*

cautiously in IE patients [176]. Inhaled aminoglycosides used in conjunction with a beta-lactam reveal better clinical outcomes [233]. For endophthalmitis and intracranial infections, they need to be administered locally (direct intravitreal injection, intraventricular administration). Aminoglycoside combination regimens diminish the emergence of resistant strains to the companion antibiotic and aminoglycoside. The synergistic antibiotic effect is observed when aminoglycoside is combined with an anti-cell wall antibiotic (beta-lactam). This combination is effective in the therapy of MSSA, enterococci, *pseudomonas spp,* and *Streptococcal viridans* infections but not in MRSA infections.
